These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study. Fagan AM; Henson RL; Li Y; Boerwinkle AH; Xiong C; Bateman RJ; Goate A; Ances BM; Doran E; Christian BT; Lai F; Rosas HD; Schupf N; Krinsky-McHale S; Silverman W; Lee JH; Klunk WE; Handen BL; Allegri RF; Chhatwal JP; Day GS; Graff-Radford NR; Jucker M; Levin J; Martins RN; Masters CL; Mori H; Mummery CJ; Niimi Y; Ringman JM; Salloway S; Schofield PR; Shoji M; Lott IT; ; Lancet Neurol; 2021 Aug; 20(8):615-626. PubMed ID: 34302786 [TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease. Melah KE; Lu SY; Hoscheidt SM; Alexander AL; Adluru N; Destiche DJ; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Gleason CE; Dowling NM; Bratzke LC; Rowley HA; Sager MA; Asthana S; Johnson SC; Bendlin BB J Alzheimers Dis; 2016; 50(3):873-86. PubMed ID: 26836182 [TBL] [Abstract][Full Text] [Related]
25. Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study. Rådestig MA; Skoog J; Zetterberg H; Skillbäck T; Zettergren A; Sterner TR; Fässberg MM; Sacuiu S; Waern M; Wetterberg H; Blennow K; Skoog I; Kern S J Alzheimers Dis; 2023; 91(1):291-303. PubMed ID: 36617786 [TBL] [Abstract][Full Text] [Related]
26. Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation. Fialova L; Bartos A; Svarcova J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):286-295. PubMed ID: 28947837 [TBL] [Abstract][Full Text] [Related]
27. A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias. Bolsewig K; Hok-A-Hin YS; Sepe FN; Boonkamp L; Jacobs D; Bellomo G; Paoletti FP; Vanmechelen E; Teunissen CE; Parnetti L; Willemse EAJ J Alzheimers Dis; 2022; 90(1):363-380. PubMed ID: 36120776 [TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia. Giuffrè GM; Quaranta D; Costantini EM; Citro S; Martellacci N; De Ninno G; Vita MG; Guglielmi V; Rossini PM; Calabresi P; Marra C Neurobiol Dis; 2023 Oct; 186():106267. PubMed ID: 37652185 [TBL] [Abstract][Full Text] [Related]
35. Blood Neurofilament Light Chain in Different Types of Dementia. Gu L; Shu H; Wang Y; Wang P Curr Alzheimer Res; 2023; 20(3):149-160. PubMed ID: 37264656 [TBL] [Abstract][Full Text] [Related]
36. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Gaetani L; Höglund K; Parnetti L; Pujol-Calderon F; Becker B; Eusebi P; Sarchielli P; Calabresi P; Di Filippo M; Zetterberg H; Blennow K Alzheimers Res Ther; 2018 Jan; 10(1):8. PubMed ID: 29370869 [TBL] [Abstract][Full Text] [Related]